Detection of methicillin-resistant staphylococcus aureus
AssigneeAdvanDx, Inc.
InventorsHenrik Stender, Anne Karin Ildor Rasmussen, Mark J. Fiandaca
Life of this patent
Estimating the term…
Loading patent…
AssigneeAdvanDx, Inc.
InventorsHenrik Stender, Anne Karin Ildor Rasmussen, Mark J. Fiandaca
Estimating the term…
This invention relates to the use of genetic probes for detection of the presence of the SCCmec cassette in Staphylococcus aureus. In one aspect, the invention allows specific detection and identification of methicillin-resistant S. aureus (MRSA) in a clinical sample without interference from the presence of other non-S. aureus methicillin-resistant staphylococci. In another aspect, the invention allows specific detection and identification of methicillin-resistant coagulase negative staphylococci (MRCNS) originating from a clinical sample without interference from the presence of methicillin-resistant S. aureus.
A kit for detection of SCCmec in Staphylococcus aureus, the kit comprising:
A kit for detection of SCCmec in Staphylococcus aureus, the kit comprising:
A method of testing a sample for the presence or absence of SCCmec cassette DNA in DNA of Staphylococcus aureus, the method comprising:
A method of testing a sample for the presence or absence of SCCmec cassette DNA in DNA of a plurality of Staphylococcus species, the method comprising:
A probe set for detecting, identifying or quantitating methicillin resistant Staphylococcus aureus (MRSA) or methicillin resistant coagulase negative staphylococci (MRCNS) in a sample, comprising:
Dependencies are inferred from the claim text.